Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Larsen

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Lipid Research|February 19, 2014
The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseasesJames A Shayman, Scott D Larsen
Chemical Communications (Cambridge, England)|May 24, 2012
Efficient, divergent synthesis of cryptophycin unit A analoguesKyle L Bolduc, Scott D Larsen, David H Sherman
Molecular Pharmacology|February 25, 2018
Gedunin- and Khivorin-Derivatives Are Small-Molecule Partial Agonists for Adhesion G Protein-Coupled Receptors GPR56/ADGRG1 and GPR114/ADGRG5Hannah M Stoveken, Scott D Larsen, Alan V Smrcka, et al.
Journal of Medicinal Chemistry|April 19, 2002
Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activityCharlotta Liljebris, Scott D Larsen, Derek Ogg, et al.
Pediatric Surgery International|September 28, 2016
Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine modelsManabu Okawada, Michael W Wilson, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
A catch-and-release strategy for the combinatorial synthesis of 4-acylamino-1,3-thiazoles as potential CDK5 inhibitorsScott D Larsen, Carl F Stachew, Paula M Clare, et al.
RSC Advances|June 25, 2021
AC2P20 selectively kills <i>Mycobacterium tuberculosis</i> at acidic pH by depleting free thiolsShelby J Dechow, Garry B Coulson, Michael W Wilson, et al.
Pharmacology Research & Perspectives|November 25, 2022
Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathwayKendell M Pawelec, Megan Varnum, Jack R Harkema, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2018
Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitorsHelen V Waldschmidt, Renee Bouley, Paul D Kirchhoff, et al.
Beilstein Journal of Organic Chemistry|June 15, 2013
Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathwayJessica L Bell, Andrew J Haak, Susan M Wade, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Lipid Research|February 19, 2014
The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseasesJames A Shayman, Scott D Larsen
Chemical Communications (Cambridge, England)|May 24, 2012
Efficient, divergent synthesis of cryptophycin unit A analoguesKyle L Bolduc, Scott D Larsen, David H Sherman
Molecular Pharmacology|February 25, 2018
Gedunin- and Khivorin-Derivatives Are Small-Molecule Partial Agonists for Adhesion G Protein-Coupled Receptors GPR56/ADGRG1 and GPR114/ADGRG5Hannah M Stoveken, Scott D Larsen, Alan V Smrcka, et al.
Journal of Medicinal Chemistry|April 19, 2002
Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activityCharlotta Liljebris, Scott D Larsen, Derek Ogg, et al.
Pediatric Surgery International|September 28, 2016
Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine modelsManabu Okawada, Michael W Wilson, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
A catch-and-release strategy for the combinatorial synthesis of 4-acylamino-1,3-thiazoles as potential CDK5 inhibitorsScott D Larsen, Carl F Stachew, Paula M Clare, et al.
RSC Advances|June 25, 2021
AC2P20 selectively kills <i>Mycobacterium tuberculosis</i> at acidic pH by depleting free thiolsShelby J Dechow, Garry B Coulson, Michael W Wilson, et al.
Pharmacology Research & Perspectives|November 25, 2022
Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathwayKendell M Pawelec, Megan Varnum, Jack R Harkema, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2018
Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitorsHelen V Waldschmidt, Renee Bouley, Paul D Kirchhoff, et al.
Beilstein Journal of Organic Chemistry|June 15, 2013
Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathwayJessica L Bell, Andrew J Haak, Susan M Wade, et al.
Pageof 9